The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: A pilot study

Wen Tien Wu, Ru Ping Lee, Chih Hsien Wang, Te Chao Fang, Nien Tsung Lin, Ing Ho Chen, Bang Gee Hsu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Aim: Osteoprotegerin (OPG) is a potent inhibitor of osteoclasts and plays an important role in bone metabolism. Relatively high serum levels of OPG have been observed in postmenopausal women with osteoporosis compared with age-matched controls. No data, however, are available on the relationship between low bone density and serum OPG levels in postmenopausal hemodialysis (HD) patients. Methods: The enrolled subjects included 28 postmenopausal HD patients and 28 age-matched postmenopausal women with normal renal function as controls. Bone mineral density (BMD) was measured by dual energy x-ray absorptiometry (DEXA) in both hips. Low BMD was defined as femoral neck T-score 2=0.262, p=0.003) was an independent predictor of low BMD in postmenopausal HD patients and explained 26.2% of the variance. Conclusions: Serum OPG is associated with low BMD in postmenopausal HD patients.

Original languageEnglish
Pages (from-to)785-790
Number of pages6
JournalJournal of Women's Health
Volume19
Issue number4
DOIs
Publication statusPublished - Apr 1 2010
Externally publishedYes

Fingerprint

Osteoprotegerin
Postmenopausal Osteoporosis
Bone Density
Renal Dialysis
Serum
Femur Neck
Osteoclasts
Osteoporosis
Hip
X-Rays
Kidney
Bone and Bones

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients : A pilot study. / Wu, Wen Tien; Lee, Ru Ping; Wang, Chih Hsien; Fang, Te Chao; Lin, Nien Tsung; Chen, Ing Ho; Hsu, Bang Gee.

In: Journal of Women's Health, Vol. 19, No. 4, 01.04.2010, p. 785-790.

Research output: Contribution to journalArticle

Wu, Wen Tien ; Lee, Ru Ping ; Wang, Chih Hsien ; Fang, Te Chao ; Lin, Nien Tsung ; Chen, Ing Ho ; Hsu, Bang Gee. / The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients : A pilot study. In: Journal of Women's Health. 2010 ; Vol. 19, No. 4. pp. 785-790.
@article{c5019691c13e4a1a96692b7017006cdd,
title = "The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: A pilot study",
abstract = "Aim: Osteoprotegerin (OPG) is a potent inhibitor of osteoclasts and plays an important role in bone metabolism. Relatively high serum levels of OPG have been observed in postmenopausal women with osteoporosis compared with age-matched controls. No data, however, are available on the relationship between low bone density and serum OPG levels in postmenopausal hemodialysis (HD) patients. Methods: The enrolled subjects included 28 postmenopausal HD patients and 28 age-matched postmenopausal women with normal renal function as controls. Bone mineral density (BMD) was measured by dual energy x-ray absorptiometry (DEXA) in both hips. Low BMD was defined as femoral neck T-score 2=0.262, p=0.003) was an independent predictor of low BMD in postmenopausal HD patients and explained 26.2{\%} of the variance. Conclusions: Serum OPG is associated with low BMD in postmenopausal HD patients.",
author = "Wu, {Wen Tien} and Lee, {Ru Ping} and Wang, {Chih Hsien} and Fang, {Te Chao} and Lin, {Nien Tsung} and Chen, {Ing Ho} and Hsu, {Bang Gee}",
year = "2010",
month = "4",
day = "1",
doi = "10.1089/jwh.2009.1577",
language = "English",
volume = "19",
pages = "785--790",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert, Inc., publishers",
number = "4",

}

TY - JOUR

T1 - The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients

T2 - A pilot study

AU - Wu, Wen Tien

AU - Lee, Ru Ping

AU - Wang, Chih Hsien

AU - Fang, Te Chao

AU - Lin, Nien Tsung

AU - Chen, Ing Ho

AU - Hsu, Bang Gee

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Aim: Osteoprotegerin (OPG) is a potent inhibitor of osteoclasts and plays an important role in bone metabolism. Relatively high serum levels of OPG have been observed in postmenopausal women with osteoporosis compared with age-matched controls. No data, however, are available on the relationship between low bone density and serum OPG levels in postmenopausal hemodialysis (HD) patients. Methods: The enrolled subjects included 28 postmenopausal HD patients and 28 age-matched postmenopausal women with normal renal function as controls. Bone mineral density (BMD) was measured by dual energy x-ray absorptiometry (DEXA) in both hips. Low BMD was defined as femoral neck T-score 2=0.262, p=0.003) was an independent predictor of low BMD in postmenopausal HD patients and explained 26.2% of the variance. Conclusions: Serum OPG is associated with low BMD in postmenopausal HD patients.

AB - Aim: Osteoprotegerin (OPG) is a potent inhibitor of osteoclasts and plays an important role in bone metabolism. Relatively high serum levels of OPG have been observed in postmenopausal women with osteoporosis compared with age-matched controls. No data, however, are available on the relationship between low bone density and serum OPG levels in postmenopausal hemodialysis (HD) patients. Methods: The enrolled subjects included 28 postmenopausal HD patients and 28 age-matched postmenopausal women with normal renal function as controls. Bone mineral density (BMD) was measured by dual energy x-ray absorptiometry (DEXA) in both hips. Low BMD was defined as femoral neck T-score 2=0.262, p=0.003) was an independent predictor of low BMD in postmenopausal HD patients and explained 26.2% of the variance. Conclusions: Serum OPG is associated with low BMD in postmenopausal HD patients.

UR - http://www.scopus.com/inward/record.url?scp=77951813984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951813984&partnerID=8YFLogxK

U2 - 10.1089/jwh.2009.1577

DO - 10.1089/jwh.2009.1577

M3 - Article

C2 - 20210559

AN - SCOPUS:77951813984

VL - 19

SP - 785

EP - 790

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 4

ER -